Literature DB >> 26550149

Effects of calcitriol on structural changes of kidney in C57BL/6J mouse model.

Khalid M Alkharfy1, Mukhtar Ahmed2, Sobhy M Yakout3, Nasser M Al-Daghri3.   

Abstract

Thisaim of the studyisto investigate the effects of calcitriol (vitamin D) on mouse kidneys under obese conditions. Male C57BL/6J mice were maintained on either low fat diet (LFD) or high fat diet (HFD) with/without calcitriol treatment (150 IU/kg/day) for 16 consecutive weeks. Results of HFD fed mice demonstrated more weight gain and showed numerous structural abnormalities in the corticomedullary region compared to those under control and LFD conditions. Near nephropathy condition in HFD mice were characterized by damage in renal tubules, including dilatation of interstitial cells and blood vessels. Furthermore, exfoliation and shedding of proximal tubular cells takes place. The conditions further worsen by thickening the basement membrane and interstitial inflammation, as evidenced by abundant interstitial debris. Additionally, a large number of degenerated mitochondria, fat droplets, lysosomal bodies' mesangial expansion, and cellular debris were found throughout the kidney. Sustained cell hypertrophy was also evident by transmission electron microscope confirming a marked increase in degeneration of cells within renal areas. No significant variances were detected in the glomerulus' area and diameter in both low and high fat diets with/without calcitriol treatment as well as inner and outer diameters of both distal and proximal tubule in all groups. Evidently, calcitriolcould act as a protective agent to normalize kidney structure in obese condition. This study suggests that calcitriol could normalize the function of kidney and protect its structural integrity in obesity.

Entities:  

Keywords:  C57BL/6J mouse; Calcitriol; high fat diet; kidney; obesity; pathological changes

Year:  2015        PMID: 26550149      PMCID: PMC4612834     

Source DB:  PubMed          Journal:  Int J Clin Exp Med        ISSN: 1940-5901


  24 in total

1.  Prevention of fat-induced insulin resistance by salicylate.

Authors:  J K Kim; Y J Kim; J J Fillmore; Y Chen; I Moore; J Lee; M Yuan; Z W Li; M Karin; P Perret; S E Shoelson; G I Shulman
Journal:  J Clin Invest       Date:  2001-08       Impact factor: 14.808

2.  High-fat diet in low-dose-streptozotocin-treated heminephrectomized rats induces all features of human type 2 diabetic nephropathy: a new rat model of diabetic nephropathy.

Authors:  Mikio Sugano; Hideyuki Yamato; Tsutomu Hayashi; Hiromi Ochiai; Junji Kakuchi; Sumie Goto; Fuyuhiko Nishijima; Noriaki Iino; Junichiro James Kazama; Tsukasa Takeuchi; Osamu Mokuda; Toshio Ishikawa; Ryo Okazaki
Journal:  Nutr Metab Cardiovasc Dis       Date:  2006-02-08       Impact factor: 4.222

3.  Diet-induced obesity in C57BL/6J mice causes increased renal lipid accumulation and glomerulosclerosis via a sterol regulatory element-binding protein-1c-dependent pathway.

Authors:  Tao Jiang; Zhuowei Wang; Gregory Proctor; Shevie Moskowitz; Scott E Liebman; Thomas Rogers; M Scott Lucia; Jinping Li; Moshe Levi
Journal:  J Biol Chem       Date:  2005-07-25       Impact factor: 5.157

Review 4.  Noncalcemic actions of vitamin D receptor ligands.

Authors:  Sunil Nagpal; Songqing Na; Radhakrishnan Rathnachalam
Journal:  Endocr Rev       Date:  2005-03-29       Impact factor: 19.871

Review 5.  Pathology of nonalcoholic fatty liver disease.

Authors:  Elizabeth M Brunt
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2010-03-02       Impact factor: 46.802

Review 6.  Vitamin D and outcomes in chronic kidney disease.

Authors:  Steven Cheng; Daniel Coyne
Journal:  Curr Opin Nephrol Hypertens       Date:  2007-03       Impact factor: 2.894

Review 7.  Optimization of hypolipidemic and antiplatelet treatment in the diabetic patient with renal disease.

Authors:  Mariella Trovati; Franco Cavalot
Journal:  J Am Soc Nephrol       Date:  2004-01       Impact factor: 10.121

8.  Chronic kidney disease, hypovitaminosis D, and mortality in the United States.

Authors:  Rajnish Mehrotra; Dulcie A Kermah; Isidro B Salusky; Myles S Wolf; Ravi I Thadhani; Yi-Wen Chiu; David Martins; Sharon G Adler; Keith C Norris
Journal:  Kidney Int       Date:  2009-08-05       Impact factor: 10.612

9.  Vitamin D supplementation in patients with diabetes mellitus type 2 on different therapeutic regimens: a one-year prospective study.

Authors:  Khalid M Alkharfy; Nasser M Al-Daghri; Shaun B Sabico; Abdulaziz Al-Othman; Osama Moharram; Majed S Alokail; Yousef Al-Saleh; Sudhesh Kumar; George P Chrousos
Journal:  Cardiovasc Diabetol       Date:  2013-08-07       Impact factor: 9.951

10.  Genomic actions of 1,25-dihydroxyvitamin D3 on insulin receptor gene expression, insulin receptor number and insulin activity in the kidney, liver and adipose tissue of streptozotocin-induced diabetic rats.

Authors:  Consuelo Calle; Begoña Maestro; Moisés García-Arencibia
Journal:  BMC Mol Biol       Date:  2008-07-18       Impact factor: 2.946

View more
  1 in total

Review 1.  An Updated Mini Review of Vitamin D and Obesity: Adipogenesis and Inflammation State.

Authors:  Zujaja-Tul-Noor Hamid Mehmood; Dimitrios Papandreou
Journal:  Open Access Maced J Med Sci       Date:  2016-09-06
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.